title: Linezolid induces ring sideroblasts.
authors.affiliation: claude.preudhomme@chru-lille.fr.
authors.forename: Christophe
authors.initials: C
authors.lastname: Willekens
authors.forename: Florent
authors.initials: F
authors.lastname: Dumezy
authors.forename: Thomas
authors.initials: T
authors.lastname: Boyer
authors.forename: Aline
authors.initials: A
authors.lastname: Renneville
authors.forename: Julien
authors.initials: J
authors.lastname: Rossignol
authors.forename: Céline
authors.initials: C
authors.lastname: Berthon
authors.forename: Angélique
authors.initials: A
authors.lastname: Cotteau-Leroy
authors.forename: Lotfi
authors.initials: L
authors.lastname: Mehiaoui
authors.forename: Bruno
authors.initials: B
authors.lastname: Quesnel
authors.forename: Claude
authors.initials: C
authors.lastname: Preudhomme
mesh_terms: D000081:Acetamides / Q000009:adverse effects*; D000328:Adult; D000368:Aged; D000756:Anemia, Sideroblastic / Q000097:blood* / Q000139:chemically induced* / Q000175:diagnosis; D000890:Anti-Infective Agents / Q000009:adverse effects*; D001854:Bone Marrow Cells / Q000187:drug effects / Q000473:pathology; D015331:Cohort Studies; D005260:Female; D006801:Humans; D000069349:Linezolid; D008297:Male; D008875:Middle Aged; D023303:Oxazolidinones / Q000009:adverse effects*; D012189:Retrospective Studies
chemical_list: D000081:Acetamides; D000890:Anti-Infective Agents; D023303:Oxazolidinones; D000069349:Linezolid
keywords: hematologic toxicity; linezolid; ring sideroblasts; sideroblastic anemia